ABRAXANE® Approved by European Commission for First-Line Treatment of Patients with Non-Small Cell Lung Cancer

… Lung Cancer Nanotechnology Therapy Now Available for Patients in European Union with Lung Cancer … . Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting … advanced or metastatic non-small cell lung cancer (NSCLC), in combination with carboplatin …